(Q44255513)

English

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year resu

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year resu (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

breast carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Saul E Rivkin

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Stephanie J Green

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Danika Lew

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

John J Costanzi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

John W Athens

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

C Kent Osborne

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clarence B Vaughn

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Silvana Martino

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

21-29

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

American Joint Committee on Cancer prognostic factors consensus conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemotherapy and surgery in breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of prophylactic cytotoxic chemotherapy in potentially curable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10982

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.10982

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44255513&oldid=2108937961"